Pathway Financial Advisers LLC Sells 543 Shares of Nutrien Ltd. (NYSE:NTR)

Pathway Financial Advisers LLC reduced its position in shares of Nutrien Ltd. (NYSE:NTR) by 1.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,145 shares of the company’s stock after selling 543 shares during the period. Pathway Financial Advisers LLC’s holdings in Nutrien were worth $1,349,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in NTR. Silchester International Investors LLP increased its holdings in shares of Nutrien by 9.5% during the fourth quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company’s stock worth $523,268,000 after buying an additional 1,009,895 shares in the last quarter. ARGA Investment Management LP increased its holdings in Nutrien by 25.7% during the 4th quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock valued at $270,396,000 after purchasing an additional 1,236,671 shares in the last quarter. National Bank of Canada FI raised its position in Nutrien by 4.1% in the 3rd quarter. National Bank of Canada FI now owns 4,232,211 shares of the company’s stock valued at $203,380,000 after purchasing an additional 165,582 shares during the last quarter. Toronto Dominion Bank raised its position in Nutrien by 11.9% in the 3rd quarter. Toronto Dominion Bank now owns 4,220,354 shares of the company’s stock valued at $202,830,000 after purchasing an additional 447,413 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Nutrien in the third quarter worth $150,181,000. 63.10% of the stock is owned by institutional investors.

Nutrien Price Performance

NYSE NTR opened at $49.91 on Thursday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The stock has a market cap of $24.51 billion, a price-to-earnings ratio of 33.50, a PEG ratio of 1.13 and a beta of 0.81. The business has a 50 day simple moving average of $48.91 and a 200 day simple moving average of $48.12. Nutrien Ltd. has a 52-week low of $43.69 and a 52-week high of $60.87.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Oppenheimer started coverage on Nutrien in a report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 price target for the company. JPMorgan Chase & Co. raised shares of Nutrien from an “underweight” rating to a “neutral” rating and boosted their target price for the stock from $40.00 to $50.00 in a research note on Monday, January 13th. Piper Sandler upped their target price on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Barclays reissued an “equal weight” rating and issued a $56.00 price target (up previously from $55.00) on shares of Nutrien in a report on Tuesday, January 21st. Finally, Scotiabank upped their price objective on Nutrien from $59.00 to $60.00 and gave the stock a “sector outperform” rating in a report on Monday. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, Nutrien has a consensus rating of “Moderate Buy” and a consensus target price of $59.00.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.